Lung Cancer
From the Journals
Study: Shared decision-making in lung cancer screening needs work
A cross-sectional study reports a host of shortcomings with shared decision-making between providers and patients in lung cancer screening.
From the Journals
Researchers identify four small cell lung cancer subtypes and their best therapies
News
FDA approves cemiplimab-rwlc for NSCLC with PD-L1 expression
This approval “means physicians and patients have a potent new treatment option against this deadly disease.”
Feature
Organ transplant patient dies after receiving COVID-19–infected lungs
A surgeon who handled the donor lungs was also infected with the virus and fell ill but later recovered.
News from the FDA/CDC
FDA approves first drug that protects against chemo-induced myelosuppression
Conference Coverage
‘Unprecedented’ long-term survival after immunotherapy in pretreated NSCLC
Conference Coverage
Model could reduce some disparities in lung cancer screening
Conference Coverage
Customized chemotherapy did not improve survival in early NSCLC
Toxicity was less common with customized therapy.
Conference Coverage
Neoadjuvant atezolizumab safe for patients with resectable lung cancer
Neoadjuvant atezolizumab was deemed “effective, well tolerated, and surgically acceptable.”
Conference Coverage
Sotorasib in NSCLC: ‘Historic milestone’ reached
Phase 2 results with sotorasib support phase 1 results reported last year.